| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.062 | 0.05 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.05 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | -0.065 | 0.05 |
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.098 | 0.05 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.081 | 0.05 |
| mRNA | GSK-J4 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.05 |
| mRNA | CIL56 | CTRPv2 | pan-cancer | AAC | -0.085 | 0.06 |
| mRNA | Bleomycin | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |